ACACIA PHARMA
Acacia Pharma Ltd., a pharmaceutical company, discovers and develops supportive care drugs. The company focuses on cancer supportive care. Its products include APD405, an injectable formulation of an oral drug for the use of nausea and vomiting; APD209, which is for the use of cancer cachexia; and APD421, an intravenous formulation for the use of prevention and treatment of nausea and vomiting. The company also concentrates its discovery efforts in cancer related fatigue, cancer cachexia, and xerostomia. Acacia Pharma Ltd. was incorporated in 2006 and is based in Cambridge, United Kingdom.
ACACIA PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2006-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.acaciapharma.com
Total Employee:
11+
Status:
Active
Contact:
+441223875130
Total Funding:
63.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Acacia Pharma
Novo Holdings
Novo Holdings investment in Series B - Acacia Pharma
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Acacia Pharma
F-Prime Capital
F-Prime Capital investment in Series B - Acacia Pharma
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series B - Acacia Pharma
Gilde Healthcare
Gilde Healthcare investment in Series B - Acacia Pharma
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series A - Acacia Pharma
Gilde Healthcare
Gilde Healthcare investment in Series A - Acacia Pharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-06-04 | Cosmo Pharmaceuticals | Acacia Pharma investment in Post-IPO Debt - Cosmo Pharmaceuticals | 25 M USD |
Official Site Inspections
http://www.acaciapharma.com Semrush global rank: 4.86 M Semrush visits lastest month: 1.83 K
- Host name: ec2-52-1-123-40.compute-1.amazonaws.com
- IP address: 52.1.123.40
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
